Clinical Trial Update: A Trial to Reduce Delirium in Aged Post Acute Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by the National Institute on Aging to reduce delirium in older post-acute patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Delirium, Aging | Phase 3 | Status: COMPLETED